JUNSHI BIO (01877) announced that Mr. Xiong Jun, a controlling shareholder, one of the actual controllers, and Chairman of the Board of Shanghai Junshi Biosciences Co., Ltd., plans to increase his holdings of the company's A-shares and H-shares over a 12-month period starting April 12, 2025. The share purchases will be conducted through methods permitted by the Shanghai Stock Exchange and The Stock Exchange of Hong Kong Limited, including but not limited to centralized bidding and block trades. The total value of the planned share acquisitions is not less than RMB 100 million, with the portion allocated to A-shares being no less than RMB 50 million. As of the date of this announcement, Mr. Xiong Jun has already purchased a cumulative total of 365,400 A-shares via the Shanghai Stock Exchange's centralized bidding system. These shares represent approximately 0.04% of the company's total share capital, with a cumulative transaction value of RMB 12.2066 million. This share acquisition plan is not yet complete. Mr. Xiong Jun will continue to increase his holdings in the company at opportune times during the implementation period of the plan.